Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.13% dropped 0.98% to $179.62 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.06% rising 0.95% to 3,978.73 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.05% rising 0.60% to 32,120.28. The stock's fall snapped a three-day winning streak. Johnson & Johnson closed $7.07 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +1.62% fell 1.16% to $344.87, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.37% fell 0.94% to $93.75, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.23% rose 0.56% to $53.71. Trading volume (6.5 M) remained 1.1 million below its 50-day average volume of 7.6 M.